Success Metrics

Clinical Success Rate
100.0%

Based on 15 completed trials

Completion Rate
100%(15/15)
Active Trials
0(0%)
Results Posted
87%(13 trials)

Phase Distribution

Ph phase_2
1
7%
Ph phase_1
14
93%

Phase Distribution

14

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution15 total trials
Phase 1Safety & dosage
14(93.3%)
Phase 2Efficacy & side effects
1(6.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

15 of 15 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

15

all time

Status Distribution
Completed(15)

Detailed Status

Completed15

Development Timeline

Analytics

Development Status

Total Trials
15
Active
0
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 114 (93.3%)
Phase 21 (6.7%)

Trials by Status

completed15100%

Recent Activity

Clinical Trials (15)

Showing 15 of 15 trials
NCT05076409Phase 1

A Study in Healthy Men to Test How Fluconazole Influences the Amount of BI 425809 in the Blood

Completed
NCT02362516Phase 1

Pharmacokinetics and Pharmacodynamic Effect of Different Multiple Oral Doses of BI 425809

Completed
NCT05347004Phase 1

A Study in Healthy People to Test How BI 425809 is Taken up in the Body When Taken With or Without Food

Completed
NCT02783040Phase 1

Interaction of BI 425809 With Midazolam, Warfarin, Omeprazole and Digoxin

Completed
NCT02383888Phase 1

Single Rising Dose Trial of BI 425809 for Healthy Japanese and Chinese Male Subjects

Completed
NCT05718843Phase 1

A Study to Test How Iclepertin is Taken up in the Blood of People With and Without Kidney Problems

Completed
NCT05723874Phase 1

A Study in Healthy Men to Test Whether Bosentan Influences the Amount of BI 425809 in the Blood

Completed
NCT03082183Phase 1

A Study in Healthy Men to Test Whether Rifampicin Influences the Amount of BI 425809 in the Blood

Completed
NCT03783000Phase 1

A Study in Healthy Men to Measure the Amount of BI 425809 in the Blood When Taken as a Tablet

Completed
NCT02337283Phase 1

Safety, Tolerability, and Pharmacokinetics of Multiple Rising Doses of BI 425809 Tablets for 12 Days to Young and Elderly Healthy Male and Female Volunteers and Comparison of Pharmacokinetics of a Single Oral Dose of BI 425809 (Morning Versus Evening)

Completed
NCT02342717Phase 1

Relative Bioavailability of a Single Oral Dose of BI 425809 When Administered Alone or in Combination With Multiple Oral Doses of Itraconazole in Healthy Male Subjects

Completed
NCT04602221Phase 1

A Study in Healthy Men to Test Whether BI 409306, BI 425809 or Lamotrigine Can Reverse the Memory Problems Caused by Ketamine

Completed
NCT03859973Phase 2

This Study Tests Whether BI 425809 Together With Brain Training Using a Computer Improves Mental Functioning in Patients With Schizophrenia

Completed
NCT03988803Phase 1

A Study in Healthy Men and Women to Test Which Effects Memantine and BI 425809 Have on Each Other

Completed
NCT03905096Phase 1

A Study in Healthy Men and Women to Test Which Effects Donepezil and BI 425809 Have on Each Other

Completed

All 15 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
15